Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degeneration (ARMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT04919096
What this trial is testing

Study of SCB-420 in Subjects With Neovascular Age-related Macular Degeneration

Who this might be right for
Wet Age-related Macular Degeneration
Clover Biopharmaceuticals AUS Pty
Testing effectiveness (Phase 2)Study completedNCT00570193
What this trial is testing

Photodynamic and Pharmacologic Treatment of CNV

Who this might be right for
Choroidal NeovascularizationMacular Degeneration
Mid-Atlantic Retina Consultations, Inc. 41
Not applicableStudy completedNCT02224963
What this trial is testing

Macular Degeneration and Aging Study

Who this might be right for
Age-related Macular Degeneration
University of Rochester 216
Post-approval studies (Phase 4)Study completedNCT01006538
What this trial is testing

Macular EpiRetinal Brachytherapy Versus Lucentis® Only Treatment (MERLOT)

Who this might be right for
Macular Degeneration
King's College Hospital NHS Trust 363
Early research (Phase 1)Study completedNCT00765921
What this trial is testing

Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma

Who this might be right for
Choroidal Melanoma
Massachusetts Eye and Ear Infirmary 40
Testing effectiveness (Phase 2)Study completedNCT01972763
What this trial is testing

Ranibizumab for Recalcitrant Wet Age-related Macular Degeneration in Eyes Previously Switched From Bevacizumab and/or Ranibizumab to Aflibercept.

Who this might be right for
Recalcitrant Wet Age-related Macular Degeneration
Northern California Retina Vitreous Associates 12
Not applicableLooking for participantsNCT07069647
What this trial is testing

Artificial Intelligence-Aided Screening for Patients With Diabetic Retinopathy and Age-related Macular Degeneration in Family Medicine and Geriatric Medicine Outpatient Clinics

Who this might be right for
Age-Related Macular Degeneration (AMD)Diabetic Retinopathy (DR)
National Taiwan University Hospital 4,300
Testing effectiveness (Phase 2)WithdrawnNCT00135655
What this trial is testing

Denufosol Tetrasodium Intravitreal Injection in Subjects With Post Cataract Extraction Macular Edema

Who this might be right for
Macular Edema, Cystoid
Merck Sharp & Dohme LLC
Not applicableStudy completedNCT01650948
What this trial is testing

Genetic Load and Phenotype in Aggressive AMD

Who this might be right for
Age-related Macular Degeneration
Sequenom, Inc. 100
Not applicableNot Yet RecruitingNCT06989658
What this trial is testing

Feasibility and Tolerability Study of Smart Contact Lens With Healthy Subjects and Patients With Stargardt's Disease

Who this might be right for
Stargardt Disease
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts 32
Testing effectiveness (Phase 2)Looking for participantsNCT07161544
What this trial is testing

AAVB-039 in Participants With Stargardt Disease (STGD1)

Who this might be right for
Stargardt Disease
AAVantgarde Bio Srl 75
Not applicableStudy completedNCT02951351
What this trial is testing

Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections

Who this might be right for
Age-related Macular DegenerationDiabetic Macular EdemaInjection Site+2 more
Mayo Clinic 36
Large-scale testing (Phase 3)Study completedNCT00436553
What this trial is testing

Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization

Who this might be right for
Macular DegenerationChoroidal Neovascularization
Novartis 321
Not applicableLooking for participantsNCT07582042
What this trial is testing

Lesion-tailored, Fundus-controlled Perimetry in Geographic Atrophy (GA).

Who this might be right for
Geographic Atrophy From Age-related Macular Degeneration
University of Utah 50
Testing effectiveness (Phase 2)UnknownNCT00485394
What this trial is testing

The OMEGA Study: Use of Eye Drops to Treat Geographic Atrophy Associated With Age-Related Macular Degeneration (Dry AMD)

Who this might be right for
Age-Related Macular Degeneration
Othera Pharmaceuticals 198
Not applicableStudy completedNCT00358345
What this trial is testing

PreView PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 347
Not applicableStudy completedNCT03333954
What this trial is testing

Feasibility Study of Compensation for Blindness With the PRIMA System in Patients With Dry Age Related Macular Degeneration

Who this might be right for
Dry Age-related Macular Degeneration
Science Corporation 5
Testing effectiveness (Phase 2)Study completedNCT00370266
What this trial is testing

Intravitreal Triamcinolone for Acute Branch Retinal Vein Occlusion

Who this might be right for
Branch Retinal Vein Occlusion
Shahid Beheshti University of Medical Sciences 30
Large-scale testing (Phase 3)Looking for participantsNCT07419334
What this trial is testing

Study of ALK-001 on the Progression of Stargardt Disease

Who this might be right for
Stargardt Disease
Alkeus Pharmaceuticals, Inc. 230
Not applicableStudy completedNCT04641234
What this trial is testing

A Study Reviewing Medical Records to Learn More About Treat-and-extend With Eylea in Patients With Neovascular Age-related Macular Degeneration (nAMD).

Who this might be right for
Neovascular Age-related Macular Degeneration
Bayer 330
Next Page